Can deep vein thrombosis occur in the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can DVT Occur in the Foot?

Yes, deep vein thrombosis can definitely occur in the foot, though it is uncommon and often overlooked as a source of venous thromboembolism.

Clinical Significance and Location

DVT typically originates in the calf veins and extends proximally, but foot vein thrombosis represents a distinct entity that can serve as both an independent source of symptoms and a potential origin point for more proximal thrombosis 1. Historical venography studies demonstrated that foot vein thrombosis occurred in approximately 31% of patients with suspected venous thromboembolism 2, and among patients with documented DVT elsewhere in the leg, approximately 20% had associated foot vein thrombosis 3.

The plantar veins are the most commonly affected vessels in the foot, with plantar vein thrombosis presenting as unilateral plantar foot pain, edema, and a heavy sensation in the affected foot 4, 5. Mechanical trauma to the plantar surface is a recognized precipitating factor 4.

Diagnostic Approach

Current imaging guidelines focus primarily on proximal veins, which creates a diagnostic gap:

  • Complete compression ultrasound (CCUS) and complete duplex ultrasound (CDUS) protocols extend from the common femoral vein to the ankle, evaluating posterior tibial and peroneal veins in the calf 6
  • Standard ultrasound protocols may not routinely visualize foot veins unless symptoms specifically referable to the foot warrant targeted imaging 6
  • When foot pain or localized symptoms are present, dedicated ultrasound or MRI of the foot should be performed 4, 5

The ACR Appropriateness Criteria acknowledge that ultrasound has much lower sensitivity (63.5%) for distal DVT compared to proximal DVT (94.2%) 1, and this limitation extends to foot veins where visualization is technically challenging.

Clinical Management Considerations

The clinical significance of isolated foot vein thrombosis differs substantially from proximal DVT:

  • Isolated distal (below-knee) DVT rarely causes pulmonary embolism and often resolves spontaneously 1
  • However, approximately one-sixth of distal DVTs extend proximally, necessitating serial imaging at 1 week if anticoagulation is not initiated 1
  • For plantar vein thrombosis specifically, treatment ranges from conservative management with serial ultrasound to therapeutic anticoagulation for 6 months 4, 5

Treatment Algorithm for Foot DVT:

  1. If mechanical trauma is the sole risk factor and no additional thrombotic risk factors exist: Consider initial conservative management with serial ultrasound surveillance 4
  2. If additional risk factors present (prior DVT, acute trauma, advanced age, immobilization): Initiate therapeutic anticoagulation 4, 7
  3. If thrombus propagates on follow-up imaging: Convert to anticoagulation therapy 4

Important Caveats

  • Do not dismiss foot pain after lower extremity surgery or trauma - foot vein thrombosis can occur even with prophylactic anticoagulation 8, 7
  • The risk of propagation to more proximal veins exists, though it appears lower than with calf DVT when mechanical trauma is the primary etiology 4
  • Foot venography is no longer routinely performed unless symptoms specifically indicate foot involvement, as older studies suggesting routine foot imaging 2, 9 predate modern ultrasound protocols
  • Most foot DVTs are asymptomatic and discovered incidentally 7

Bottom line: While foot DVT is uncommon, it should be considered in patients with localized plantar foot pain and swelling, particularly following trauma or surgery. Targeted imaging of the foot is required for diagnosis, as standard lower extremity DVT protocols may not adequately visualize these vessels.

Related Questions

How common are deep vein thromboses (DVTs) in the ankle?
In a 70‑year‑old man with a history of deep‑vein thrombosis who is taking a direct oral anticoagulant and now presents with one day of bright red blood per rectum, what laboratory studies and imaging investigations should be ordered?
For a 75-year-old bedridden woman with acute deep‑vein thrombosis, septic shock from a sacral pressure ulcer, acute kidney injury with metabolic acidosis, intubated for suspected pulmonary embolism, normal inferior vena cava size and dilated right ventricle, what are the risks and contraindications to systemic thrombolysis versus intravenous unfractionated heparin?
What is the most appropriate initial management for a 66-year-old man who recently underwent anterior rectal resection and now has an acute deep vein thrombosis of the left popliteal vein extending to the common femoral junction?
What cream should be recommended for a 66-year-old male with a history of deep vein thrombosis (DVT) and an inferior vena cava (IVC) filter who wears thigh-length thrombo‑embolectomy device (TED) stockings and has sensitive skin irritation from the stockings?
Is it appropriate to administer rizatriptan to a woman who has no history of coronary artery disease, uncontrolled hypertension, peripheral vascular disease, cerebrovascular disease, hemiplegic migraine, and who is not pregnant or breastfeeding?
What are the normal fasting (morning) blood glucose levels and the normal 2‑hour post‑prandial blood glucose levels?
Should low-dose aspirin (81 mg daily) be given to patients with mild to moderate coronary artery stenosis?
Can telmisartan cause elevated serum glutamic‑pyruvic transaminase (SGPT/ALT)?
What is the current status of research on stem‑cell‑derived pancreatic islet cells?
Is there any new data on a direct head‑to‑head comparison of tirzepatide versus retatrutide as studied in the TRIUMPH‑5 trial?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.